13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-07-22 Event 2026-07-20 SEC 0001346824-26-000199 →

RA CAPITAL MANAGEMENT, L.P. Freenome, Inc. PCSC

Stake: Shares: 15,367,270 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
77 filings by this filer
76 other filings in the data moat
Short Interest · settle 2026-06-30
DTC 5.38
721,849 shares short · -5.2% vs prior

Other 13D/G Filings on Freenome, Inc.

FiledFormFilerStakeShares
2026-07-08 SCHEDULE 13G Point72 Asset Management, L.P. view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

FiledFormIssuerStakeShares
2026-07-21 SCHEDULE 13D/A VOR BIOPHARMA INC. 12,937,855 view →
2026-07-20 SCHEDULE 13G Agenus Inc. view →
2026-07-07 SCHEDULE 13D/A Climb Bio, Inc. CLYM 33.00% 23,249,186 view →
2026-07-02 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 4.10% 1,985,541 view →
2026-06-26 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 6.00% 2,915,742 view →
2026-06-24 SCHEDULE 13D/A SOLID BIOSCIENCES INC. SLDB 12,036,126 view →
2026-06-22 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 3,654,307 view →
2026-06-18 SCHEDULE 13D Parabilis Medicines, Inc. PBLS 23.80% 28,933,371 view →
2026-06-15 SCHEDULE 13D/A ARTIVA BIOTHERAPEUTICS, INC. ARTV 36.60% 17,811,623 view →
2026-06-15 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 5,138,703 view →
2026-06-03 SCHEDULE 13G Editas Medicine, Inc. EDIT view →
2026-05-21 SCHEDULE 13G Sana Biotechnology, Inc. SANA view →
2026-05-14 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 6,116,140 view →
2026-05-13 SCHEDULE 13D/A ARTIVA BIOTHERAPEUTICS, INC. ARTV 16,377,468 view →
2026-01-09 SCHEDULE Cidara Therapeutics, Inc. view →
2025-11-07 SCHEDULE LENZ Therapeutics, Inc. LENZ 13.60% 4,265,106 view →
2025-11-07 SCHEDULE Sionna Therapeutics, Inc. SION 22.60% 10,071,712 view →
2025-11-03 SCHEDULE 89bio, Inc. view →
2025-10-01 SCHEDULE ARS Pharmaceuticals, Inc. SPRY 11.10% 10,940,977 view →
2025-09-30 SCHEDULE PepGen Inc. PEPG 29.20% 20,099,753 view →
Showing 20 of 76

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →